Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol (Q46191457)

20 December 2017

title

Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol (English)

1 reference

20 December 2017

author name string

H Yuan

1

1 reference

20 December 2017

Z Huang

2

1 reference

20 December 2017

G Yang

3

1 reference

20 December 2017

H Lv

4

1 reference

20 December 2017

H Sang

5

1 reference

20 December 2017

Y Yao

6

1 reference

20 December 2017

publication date

1 November 2008

1 reference

20 December 2017

Journal of International Medical Research

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 December 2017

volume

36

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

1354-1362

1 reference

20 December 2017

The genetic dissection of essential hypertension

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Genetics of hypertension: from experimental models to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Cardiac effects of beta-adrenergic receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Catecholamines and the kidney: receptors and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

The functional significance of genetic variation within the beta-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Effect of CYP2D6*10 on pharmacokinetic variability of routinely administered metoprolol in middle-aged and elderly Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Pharmacogenetics of beta-1- and beta-2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Drug reactions enzymes, and biochemical genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Antihypertensive pharmacogenetics: getting the right drug into the right patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Clinical pharmacokinetics of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600624

10.1177/147323000803600624

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017